SCHEMBL7990211

SCHEMBL7990211

COc1ccc(C)cc1/C=C/CCCCC(C)(C)OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.37
ACHE P22303 1/20 0.37
L3MBTL4 Q8NA19 1/20 0.35
L3MBTL3 Q96JM7 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP1A2 P05177 3/20 0.33
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
NFE2L2 Q16236 1/20 0.33
KDM4E B2RXH2 1/20 0.33
BACE1 P56817 1/20 0.33
MAPT P10636 5/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
NPC1 O15118 3/20 0.32
HPGD P15428 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991057 0.96 PDE5A (0.40) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL8002469 0.91 ACHE (0.40) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL12680900 0.90 PDE5A (0.36) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL7990539 0.82 L3MBTL4 (0.42) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL13845993 0.82 BACE1 (0.35) ALDH1A1CYP1A2CYP1A1CYP1B1NFE2L2
SCHEMBL12680828 0.82 L3MBTL4 (0.38) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL7991255 0.81 L3MBTL4 (0.41) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL7999209 0.81 PDE5A (0.39) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL8001694 0.79 L3MBTL4 (0.42) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1
SCHEMBL7989707 0.77 ACHE (0.38) PDE5AACHEL3MBTL4L3MBTL3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed
WO-2009079353-A1 TRIAZOLE-CONTAINING MACROCYCLIC HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-25 WO disclosed